The effects of booster vaccination on hepatitis B vaccine in anti-HBs negative infants of HBsAg-positive mothers after primary vaccination

References

• Ganem D, Prince AM. Hepatitis B virus infection--natural history and clinical consequences. N Engl J Med 2004; 350:1118 - 29; http://dx.doi.org/10.1056/NEJMra031087; PMID: 15014185
   PubMed Web of Science ®Google Scholar
• Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11:97 - 107; http://dx.doi.org/10.1046/j.1365-2893.2003.00487.x; PMID: 14996343
   PubMed Web of Science ®Google Scholar
• Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005; 34:1329 - 39; http://dx.doi.org/10.1093/ije/dyi206; PMID: 16249217
   PubMed Web of Science ®Google Scholar
• Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet 2003; 362:2089 - 94; http://dx.doi.org/10.1016/S0140-6736(03)15108-2; PMID: 14697813
   PubMed Web of Science ®Google Scholar
• Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 1995; 20:992 - 1000; http://dx.doi.org/10.1093/clinids/20.4.992; PMID: 7795104
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ma JC, Qi SX, Wang F, Zhao C, Bi SL. Effectiveness of a Chinese hamster ovary cell derived hepatitis B vaccine in Chinese rural communities. Vaccine 2011; 29:3905 - 8; http://dx.doi.org/10.1016/j.vaccine.2011.03.030; PMID: 21457729
   PubMed Web of Science ®Google Scholar
• Chang MH, Hadzic D, Rouassant SH, Jonas M, Kohn IJ, Negro F, et al, Asian Pan-Pacific Society for Pediatric Gastroenterology, Hepatology and Nutrition. Acute and chronic hepatitis: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2004; 39:Suppl 2 S584 - 8; http://dx.doi.org/10.1097/00005176-200406002-00002; PMID: 15184756
   PubMed Web of Science ®Google Scholar
• Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 2001; 135:796 - 800; PMID: 11694104
   PubMed Web of Science ®Google Scholar
• Kao JH, Hsu HM, Shau WY, Chang MH, Chen DS. Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan. J Pediatr 2001; 139:349 - 52; http://dx.doi.org/10.1067/mpd.2001.116277; PMID: 11562612
   PubMed Web of Science ®Google Scholar
• Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, et al. Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009; 27:6550 - 7; http://dx.doi.org/10.1016/j.vaccine.2009.08.048; PMID: 19729084
   PubMed Web of Science ®Google Scholar
• Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis 2009; 200:39 - 47; http://dx.doi.org/10.1086/599332; PMID: 19469708
   PubMed Web of Science ®Google Scholar
• Tsang SW, Sung JJ. Inactivated hepatitis A vaccine in Chinese patients with chronic hepatitis B infection. Aliment Pharmacol Ther 1999; 13:1445 - 9; http://dx.doi.org/10.1046/j.1365-2036.1999.00628.x; PMID: 10571600
   PubMed Web of Science ®Google Scholar
• Kato H, Nakata K, Hamasaki K, Hida D, Ishikawa H, Aritomi T, et al. Long-term efficacy of immunization against hepatitis B virus in infants at high-risk analyzed by polymerase chain reaction. Vaccine 1999; 18:581 - 7; http://dx.doi.org/10.1016/S0264-410X(99)00320-5; PMID: 10547415
   PubMed Web of Science ®Google Scholar
• Wu JS, Hwang LY, Goodman KJ, Beasley RP. Hepatitis B vaccination in high-risk infants: 10-year follow-up. J Infect Dis 1999; 179:1319 - 25; http://dx.doi.org/10.1086/314768; PMID: 10228050
   PubMed Web of Science ®Google Scholar
• Viviani S, Jack A, Hall AJ, Maine N, Mendy M, Montesano R, et al. Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age. Vaccine 1999; 17:2946 - 50; http://dx.doi.org/10.1016/S0264-410X(99)00178-4; PMID: 10462228
   PubMed Web of Science ®Google Scholar
• WHO. Hepatitis B vaccines. Wkly Epidemiol Rec 2004; 79:255 - 63; PMID: 15344666
   PubMedGoogle Scholar
• European Consensus Group on Hepatitis B Immunity. Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity. Lancet 2000; 355:561 - 5; http://dx.doi.org/10.1016/S0140-6736(99)07239-6; PMID: 10683019
   PubMed Web of Science ®Google Scholar
• Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 1999; 30:1312 - 7; http://dx.doi.org/10.1002/hep.510300511; PMID: 10534356
   PubMed Web of Science ®Google Scholar
• Beran J. Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine. Expert Rev Vaccines 2007; 6:891 - 902; http://dx.doi.org/10.1586/14760584.6.6.891; PMID: 18377352
   PubMed Web of Science ®Google Scholar
• Lu CY, Ni YH, Chiang BL, Chen PJ, Chang MH, Chang LY, et al. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis 2008; 197:1419 - 26; http://dx.doi.org/10.1086/587695; PMID: 18444799
   PubMed Web of Science ®Google Scholar
• Wang LY, Lin HH. Short-term response to a booster dose of hepatitis B vaccine in anti-HBs negative adolescents who had received primary vaccination 16 years ago. Vaccine 2007; 25:7160 - 7; http://dx.doi.org/10.1016/j.vaccine.2007.07.022; PMID: 17707557
   PubMed Web of Science ®Google Scholar
• Su FH, Cheng SH, Li CY, Chen JD, Hsiao CY, Chien CC, et al. Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination. Vaccine 2007; 25:8085 - 90; http://dx.doi.org/10.1016/j.vaccine.2007.09.013; PMID: 17920732
   PubMed Web of Science ®Google Scholar
• Gong ZY, Chen EF, Shi GX. Study on immunization effects of 5 μg and 10 μg doses and two types Genetic Engineering Hepatitis B vaccine after reinforce immunization. Chin J Publ Health 2002; 18:479 - 80
   Google Scholar
• LI YH. LI H, Gong XH. Study on reminiscent response of Hepatitis B vaccine booster immunization in 3-12 years-old children of Beijing. Chin J Publ Health 2006; 22:313 - 4
   Google Scholar
• Zhu JQ, Huang ZY, Mao DB. [Immunoreaction levels of revaccination in healthy population with hepatitis B vaccine]. Zhongguo Yi Miao He Mian Yi 2009; 15:152 - 8; PMID: 20077662
   PubMedGoogle Scholar
• Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000--summary of a workshop. Gastroenterology 2001; 120:1828 - 53; http://dx.doi.org/10.1053/gast.2001.24839; PMID: 11375963
   PubMed Web of Science ®Google Scholar
• West DJ, Margolis HS. Prevention of hepatitis B virus infection in the United States: a pediatric perspective. Pediatr Infect Dis J 1992; 11:866 - 74; http://dx.doi.org/10.1097/00006454-199210000-00012; PMID: 1408488
   PubMed Web of Science ®Google Scholar
• Yao J, Ren J, Shen L, Chen Y, Liang X, Cui F, et al. The effects of booster vaccination of hepatitis B vaccine on anti-HBV surface antigen negative children 11-15 years after primary vaccination. Hum Vaccin 2011; 7:1055 - 9; http://dx.doi.org/10.4161/hv.7.10.15990; PMID: 21989290
   PubMed Web of Science ®Google Scholar
• Lee CF, Gong Y, Brok J, Boxall EH, Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ 2006; 332:328 - 36; http://dx.doi.org/10.1136/bmj.38719.435833.7C; PMID: 16443611
   PubMed Web of Science ®Google Scholar
• del Canho R, Grosheide PM, Mazel JA, Heijtink RA, Hop WC, Gerards LJ, et al. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine 1997; 15:1624 - 30; http://dx.doi.org/10.1016/S0264-410X(97)00080-7; PMID: 9364693
   PubMed Web of Science ®Google Scholar
• Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006; 28:112 - 25; http://dx.doi.org/10.1093/epirev/mxj009; PMID: 16754644
   PubMed Web of Science ®Google Scholar
• Zheng H, Wang FZ, Chen YS. Infants’ non-and-low response after recombinant yeast derived hepatitis B vaccinated and influencing factors analysis. Chinese Journal of Vaccines and Immunization 2007; 13:303 - 5
   Google Scholar
• Isolani AP, Sversuti CS, Sell AM, Moliterno RA. Protection against hepatitis B by the Butang recombinant vaccine in newborn children in South Brazil. Mem Inst Oswaldo Cruz 2006; 101:551 - 3; http://dx.doi.org/10.1590/S0074-02762006000500012; PMID: 17072461
   PubMed Web of Science ®Google Scholar
• Pan L, Zhang W, Liang Z, Wu X, Zhu X, Li J, et al. Association between polymorphisms of the cytokine and cytokine receptor genes and immune response to hepatitis B vaccination in a Chinese Han population. J Med Virol 2012; 84:26 - 33; http://dx.doi.org/10.1002/jmv.22251; PMID: 22052597
   PubMed Web of Science ®Google Scholar
• Ze WY. Practice on planned immunology. In: Diao LD, ed. Planned Immunology. 2nd ed. Shanghai: Science and technology literature press.2001:29-65.
   Google Scholar
• Wang JJ, Yan TQ, Li QS. Study on Immune Persistence of Hepatitis B Vaccine in Newborns and the Immune Response of Boosting. China Planning Immunization 2002; 8:185 - 8
   Google Scholar
• Chen YD, Liang XF, Yao J. Evaluation on Booster Immunization Efficacy of 20 μg Recombinant Hepatitis B Vaccine Made by Recombinant Deoxyribonucleic Acid Techniques in Chinese Hamster Ovary Cell of variant dosage in children. Chin J Microbiol Immunol 2011; 657 - 8
   Google Scholar